Association of rs7372209 single nucleotide polymorphism in gene for miRNA-26a-1 with tumor localization and disease outcome in patients with colorectal cancer from Bulgaria. This is an ASCO Meeting ...
High-throughput multigene assays interrogating circulating tumor DNA (ctDNA) have the potential to significantly improve the field of precision oncology. However, existing methods are expensive and ...
Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assay
Figure 8: Major analytical performance measurements of the NeXT Personal assay. “NeXT Personal uses whole genome sequencing of tumor and matched normal samples combined with advanced analytics to ...
Evaluation methods rely on assumptions about how validation data and the data one wants to predict, called test data, are related. Traditional methods assume that validation data and test data are ...
Producing cGMP biopharmaceutical products requires controlled, consistent performance of the manufacturing process. cGMP also requires controlled, consistent performance of analytical test methods.
Laboratory-based design verification testing (DVT) of combination products and medical devices must be performed to demonstrate that the device meets the performance requirements that were set in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback